SOPHiA GENETICS SA: CEO Muken Ross sold 9,838 shares

What happened

• Muken Ross, CEO, sold 9,838 shares in an open-market sale reported on Oct 5, 2026. The filing lists a weighted average price of $8.13 and total proceeds of $79,971.

Key details

• Transaction date: Oct 5, 2026. Report filed on Oct 7, 2026 (period of report Oct 5, 2026).
• Prices: weighted average $8.13; sales executed at prices ranging from $7.91 to $8.34, inclusive (footnote F2).
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Footnotes: F1 states the shares were sold in the open market to satisfy tax withholding obligations arising from restricted stock units that vested on Oct 2, 2026 and Oct 3, 2026 and that the sales were effected under a pre-established Rule 10b5-1(c) trading plan (non-discretionary). F2 notes the weighted average price and that the reporting person will provide a breakdown of the number of shares sold at each separate price upon written request.

Why it may matter

• The filing shows shares were sold to satisfy tax withholding tied to RSU vesting and that the trades were made under a pre-established 10b5-1 plan.
• The filing does not show why the insider traded or why the company acted.